GlassScriptPhysician profile
Natalie Blum
NPI 1689024606
$1,152.11
in general payments reported to CMS, 2019-2025
17 companies · $185 in 2025
The $185 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.31 · 2020: $92.85 · 2021: $142 · 2022: $205 · 2023: $180 · 2024: $251 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $616.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $615.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $335.12 | 2019-2025 | Dyanavel Xr |
| Cranial Technologies, INC | $131.12 | 2019-2025 | Doc Band |
| Pfizer INC. | $99.27 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $96.37 | 2020-2024 | Vaxelis, Gardasil 9, M-M-R II |
| Abbvie INC. | $74.71 | 2022-2024 | |
| Sanofi Pasteur INC. | $55.57 | 2022-2023 | |
| Alk-Abello, INC | $53.76 | 2023-2025 | Odactra, Grastek, Ragwitek |
| Kaleo, INC. | $50.67 | 2020-2023 | Auvi-Q |
| Ironshore Pharmaceuticals INC. | $48.12 | 2020-2022 | |
| Collegium Pharmaceutical, INC. | $40.51 | 2025 | Jornay Pm |
| Seqirus USA INC | $33.78 | 2022-2023 | Flucelvax Quadrivalent |
| Novartis Pharmaceuticals Corporation | $29.10 | 2025 | |
| Ultragenyx Pharmaceutical INC. | $23.53 | 2025 | Dojolvi |
| Biomarin Pharmaceutical INC. | $23.37 | 2024 | Voxzogo 1.2mg |
| Acadia Pharmaceuticals INC | $22.01 | 2024 | Daybue |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verrica Pharmaceuticals INC. | $21.08 | 2024 | Ycanth |
| Alexion Pharmaceuticals, INC. | $14.02 | 2024 | Koselugo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalie Blum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.